RecallGuide.ca
    Health productsUpdated Jan 3, 2026AstraZeneca, COVISHIELDOfficial source

    AstraZeneca and COVISHIELD COVID-19 Vaccines: Risk of Capillary Leak Syndrome

    Share:

    In plain language

    This recall involves AstraZeneca COVID-19 Vaccine and COVISHIELD sold in Canada. They are being recalled because of a very rare risk of Capillary Leak Syndrome (CLS). Individuals with a history of CLS should not receive these vaccines and should discuss options with their healthcare professional.

    What to do

    • Individuals with a history of CLS should not receive these vaccines.
    • Discuss COVID-19 vaccine options with your healthcare professional.
    • Seek medical attention immediately if you develop symptoms of CLS after vaccination.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    Specific affected products are listed in the official notice.

    Why this matters

    Risk of Capillary Leak Syndrome (CLS)

    Do I have this product?

    This recall applies to specific products. Details are listed in the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Risk of Capillary Leak Syndrome (CLS)

    What should consumers do?

    Individuals with a history of CLS should not receive these vaccines. Discuss COVID-19 vaccine options with your healthcare professional. Seek medical attention immediately if you develop symptoms of CLS after vaccination.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Risk of Capillary Leak Syndrome (CLS)

    When was this product recalled?

    This product was recalled on June 29, 2021.

    Is the AstraZeneca, COVISHIELD brand affected by this recall?

    Yes, AstraZeneca, COVISHIELD products are affected by this recall. This recall involves AstraZeneca COVID-19 Vaccine and COVISHIELD sold in Canada. They are being recalled because of a very rare risk of Capillary Leak Syndrome (CLS). Individuals with a history of CLS should not receive these vaccines and should discuss options with their healthcare professional.